• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Manufacturing
    • Packaging
    • Development
    • Compliance
    • Top 25
    • Directory
    • Microsites
    • Events
    • More
  • Magazine
  • News
  • Manufacturing
  • Packaging
  • Development
  • Compliance
  • Top 25
  • Directory
  • Microsites
  • Events
  • Current / Back Issue
    Features
    Editorial
    Columns
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Subscribe Now
    Advertise Now
    Top Features
    Bye-Bye China?

    Decentralized Trials Fuel AI Revolution in Clinical Research

    Self-Medication: Flexibility for Patients and Drug Manufacturers

    The Single-Use Mixing Landscape: Evaluating Your Options

    DCAT President Talks COVID-19, Drug Manufacturing and Innovation
    Breaking News
    Online Exclusives
    Industry News
    Collaborations & Alliances
    Promotions & Moves
    Trials & Filings
    Financial Reports
    Bio News & Views
    Custom Sourcing News
    Packaging & Tracking
    CRO News
    Live From Shows
    Top News
    WDSrx Expands Warehouse Network

    Piramal Inks Clinical Supply Deal with Theratechnologies

    Recipharm Signs Manufacturing Deal with Enzymatica

    CDMO Northway Biotech Expands in U.S.

    Global Biosciences Co. Selects ValGenesis VLMS
    APIs
    Aseptic Processing
    Cleaning Validation
    Clinical Trial Materials
    Cytotoxics and High Potency Manufacturing
    Equipment
    Excipients
    Extractables and Leachables
    Facilities
    Fill/Finish
    Lyophilization
    Parenterals
    Process Development
    Process Validation
    Risk Management
    Scale-up/ Technology Transfer
    Solid Dosage/ Creams/ Ointments

    WDSrx Expands Warehouse Network

    Piramal Inks Clinical Supply Deal with Theratechnologies

    Recipharm Signs Manufacturing Deal with Enzymatica

    CDMO Northway Biotech Expands in U.S.

    Lonza to Exit Pharma Softgels and Liquid-Filled Hard Capsules
    Capsules
    Cold Chain Management
    Injectables
    Logistics
    Serialization
    Solid Dosage / Semi-solids
    Supply Chain
    Vials

    WDSrx Expands Warehouse Network

    Catalent Acquires Acorda’s INBRIJA Manufacturing Operations

    Varcode, PL Developments Form Strategic ‘Smart Tag’ Pact

    COVID-19 Vaccine Distribution: The Air Cargo Industry’s Greatest Challenge

    Thermo Fisher Expands Clinical Supply Services in Europe
    Analytical Services
    Bioanalytical Services
    Bioassay Developement
    Biologics, Proteins, Vaccines
    Biosimilars
    Chemistry
    Clinical Trials
    Drug Delivery
    Drug Development
    Drug Discovery
    Formulation Development
    Information Technology
    Laboratory Testing
    Methods Development
    Microbiology
    Preclinical Outsourcing
    R&D
    Toxicology

    Improving Product Profitability

    CDMO Northway Biotech Expands in U.S.

    Global Biosciences Co. Selects ValGenesis VLMS

    Nexelis Acquires GSK Vax Lab in Marburg

    The Future of Clinical Trials Series: Part I
    Filtration & Purification
    GMPs/GCPs
    Inspections
    QA/QC
    Regulatory Affairs
    Validation

    Global Biosciences Co. Selects ValGenesis VLMS

    Gene Therapy Co. Selects ValGenesis' SaaS Platform

    The Year of COVID: How FDA Coped with a Worldwide Pandemic in 2020 and What to Expect in 2021

    Samsung Biologics Adopts Veeva Vault QMS to Unify Quality Management

    CDMO Cognate BioServices Teams Up with L7 Informatics
    Companies
    Categories
    Corporate Capabilities
    Add New Company
    Contract Service Directory Companies
    PCI Pharma Services

    Alcami

    Cytovance Biologics

    Adare Pharma Solutions

    Syngene
    Companies
    News Releases
    Posters
    Brochures
    Services
    Videos
    Case Study
    White Papers
    Jobs
    Contract Service Directory Companies
    Alcami

    Aphena Pharma Solutions

    Adare Pharma Solutions

    PCI Pharma Services

    Baxter BioPharma Solutions
    Webinars
    Live From Shows
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
      • Enewsletter Archive
      • Digital Edition
    • Directory
      • Companies
      • Categories
      • Corporate Capabilities
      • Add Your Company
    • Manufacturing
      • APIs
      • Aseptic Processing
      • Cleaning Validation
      • Clinical Trial Materials
      • Cytotoxics and High Potency Manufacturing
      • Equipment
      • Excipients
      • Extractables and Leachables
      • Facilities
      • Fill/Finish
      • Lyophilization
      • Parenterals
      • Process Development
      • Process Validation
      • Risk Management
      • Scale-up/ Technology Transfer
      • Solid Dosage/ Creams/ Ointments
      • cGMP Manufacture
    • Packaging
      • Capsules
      • Cold Chain Management
      • Injectables
      • Logistics
      • Serialization
      • Solid Dosage / Semi-solids
      • Supply Chain
      • Vials
    • Development
      • Analytical Services
      • Bioanalytical Services
      • Bioassay Developement
      • Biologics, Proteins, Vaccines
      • Biosimilars
      • Chemistry
      • Clinical Trials
      • Drug Delivery
      • Drug Development
      • Drug Discovery
      • Formulation Development
      • Information Technology
      • Laboratory Testing
      • Methods Development
      • Microbiology
      • Preclinical Outsourcing
      • R&D
      • Toxicology
    • Compliance
      • Filtration & Purification
      • GMPs/GCPs
      • Inspections
      • QA/QC
      • Regulatory Affairs
      • Validation
    • Top 25 Pharma & BioPharma
    • Contract Pharma Direct
    • Breaking News
    • Online Exclusives
    • Slideshows
    • Experts Opinions
    • Surveys
      • Outsourcing Survey
      • Salary Survey
    • Glossary
    • Videos
    • Podcasts
    • White Papers
    • Infographics
    • Contract Pharma Conference
      • Contract Pharma Conference
      • Speakers
      • Exhibitors
      • Conference Sessions
    • Supplier Microsite
      • Companies
      • News Releases
      • Posters
      • Brochures
      • Services
      • Videos
      • Case Study
      • White Papers
    • eBook
    • Webinars
    • Events
      • Industry Events
      • Live from Show Events
      • Webinars
    • Classifieds / Job Bank
      • Classifieds
      • Job Bank
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Features

    Interactive Response Technology in Clinical Trial Supply

    Exploring the benefits of including IRT professionals earlier in trial planning

    Interactive Response Technology in Clinical Trial Supply
    Related CONTENT
    • Bioclinica Partners with Ikcon Pharma
    • Thermo Fisher Expands Direct-to-Patient Service
    • Vetio Animal Health
    • HPAPI Technology Trends
    • Be The Match BioTherapies, Cryoport Enter Agreement
    Dave Holly, Senior Manager, IRT Development and Operations, Sharp Clinical Services10.10.18
    Interactive response technology (IRT) and randomization and trial supply management (RTSM) systems provide clinical trials with essential software services such as subject enrollment, inventory management, and study drug dispensing. IRT is used to manage patient interactions and drug supplies during clinical trials and perform a range of functions for sponsors, drug depots, and investigative sites. But is that all it can do? Are today’s IRT Systems just performing the same services of 10 or even 20 years ago?

    Increasingly elaborate international clinical trials demand a smart, streamlined approach and, in the right hands, IRT can provide just that. They’re a powerful tool for accelerating a product’s progress to launch and making the management of trials simpler. However, the selection of an IRT vendor is often considered late-on in the planning of a clinical trial, which leaves sponsors at great risk of spending money on wasted drug and unplanned resupply shipments. 

    Supply chain efficiency
    Simply adding IRT to a trial does not guarantee an efficient supply chain solution. Depending upon the complexity, number of kit types, regions, countries, and dosing schedules, the resulting supply chain solution may function, but questions will remain around its efficiency and cost effectiveness. What the IRT system must be able to do is help reduce waste, limit resupply shipments, and prevent site stock-outs.

    One of the most expedient ways to achieve a successful supply chain solution is to leverage the real-world experience and advice of IRT Professionals. IRT is at the intersection of drug assignments, inventory, and resupply management, this provides professionals in the field with a very specific skill set resulting from clinical trial experiences. 

    IRT providers get to observe, first-hand, the many use case scenarios that result when sites are randomizing and dispensing study medications to trial subjects. These observational insights can prove very useful, especially when deciding how a drug will be manufactured and packaged. The advice provided by IRT vendors may prove especially useful to the small to medium-sized pharmaceutical companies that may not have in-house supply chain staff.

    Deciding how much drug to put in one package
    Early in the trial planning phase, a packaging company may suggest that money can be saved by putting more drug in one package. If a subject is to use one blister card per week for the duration of a 10-week study, putting all 10 cards into one package may look like a logical solution. IRT systems can be configured to import the kit list and dispense a 10-pack at randomization. On the surface, this also appears to be beneficial for the IRT system by eliminating the need for extra dosing visits over the 10 weeks.

    But experience reveals that trial subjects are only human and are prone to lose kits. Site users—doctors and nurses—may accidentally damage drugs, forget to refrigerate medications, or have other mishaps over the course of the trial. These human-nature factors can result in the 10-pack packaging solution costing more money, rather than the intended saving. Bulk packaging sometimes results in more shipments and more drug being wasted.

    It is important to consider how much drug would be wasted if a site, or subject, lost a 10-pack of blister cards and a replacement kit was needed. With all drug boxed in packs of 10, the subject must be issued another 10-pack kit. This means trial sites must have several 10-pack kits in reserve (buffer stock) for emergency resupplies. If the replacement is needed towards the end of the trial, most of the replacement kit will be wasted. This may also cost more if many of the 10-pack kits are left over and must be returned to the depot.

    IRT professionals can advise that dispensing one or two blister cards over several trial visits is more cost effective. The loss of a single blister card is much easier to replace than the 10-pack of blister cards and costs significantly less. Even though more IRT dispensing visits are required, there is a significant cost savings in kit replacement needs. While highly recommended for most all similar dispensing scenarios, this solution is essential for trials with expensive drugs, or with drugs in limited supplies.

    Deciding how much drug to manufacture or package
    Trying to decide how much drug to manufacture and/or package for a new trial can be very challenging. Some clients decide to package only enough for the enrollment phase of their trial.  But without considering IRT and drug usage, the stock could quickly drop by half just supplying sites with their initial inventories. 

    Discussing drug requirements with IRT professionals at an early phase brings supply chain staff together with the clinical team so that drug usage expectations can be discussed. If half of the packaged drug will be delivered to the sites upon study startup, then the inventory may not cover the expected resupply projections. Once this expectation is known it may lead to an increase of the initial supply amount. 

    The reverse scenario, packaging too much drug for study startup, can result in drug expiring before it can be used. This too is more clearly seen through IRT with the scheduling of subjects and the resupply model being used. Projections for enrollment and subject dosing visits may reveal that the initial drug inventory will expire before all subjects have completed the study. Two or more smaller manufacturing runs at key milestones will prevent site stock-outs.

    Deciding what dose levels to manufacture
    For dose escalation and titration studies, deciding what combinations of dosing quantities may also require investigation into actual drug usage and dispensation. For example, a protocol using four dosing levels of 10mg, 15mg, 20mg, and 25mg vials may require manufacturing one vial type of each dose level. Sponsors will need to explore whether it is necessary to manufacture all four vial dosing sizes, or if there is there a more cost-effective solution.

    Once again, IRT can bridge the gap between manufacturing, packaging, and the clinical team. The dispensing and resupply patterns can be discussed, which can reveal expected subject needs compared with site available inventory and capacity. Due to space limitations, especially for refrigerated medications, requiring sites to maintain an inventory of 25mg vials may reduce the site’s inventory space for other dose amounts. This can lead to shortages if emergency kit replacements are needed. The discussion may result in a decision to packing just 10mg and 15mg vials and allow the IRT system to select the correct combination of vials to dispense i.e. 20mg subjects can receive two 10mg vials, and 25mg subjects can receive one 10mg bottle and one 15mg bottle. This adjustment also provides the sites with inventory that can be used for all subjects, including any replacements. All subject can use one or both dosing sizes.  But a 25mg vial could only be used by subjects requiring the 25mg dose.

    Summary
    As IRT systems bring together sites, study medications, and subjects, IRT professionals can bring together supply chain and clinical team staff for discussions on actual trial needs. Including IRT professionals earlier in the planning phase of clinical trials may result in a better understanding of supply chain needs. This can increase the efficiency of inventory management and lead to unforeseen cost savings over the course of the trial. 


    Dave Holly is senior manager of IRT development and operations at Sharp Clinical Services. He has worked in clinical data management for over 30 years, designed several major clinical IRT systems and provided SAS programming support for many clinical trials.
    Related Searches
    • study
    • vials
    • Development
    • it
    Suggested For You
    Bioclinica Partners with Ikcon Pharma Bioclinica Partners with Ikcon Pharma
    Thermo Fisher Expands Direct-to-Patient Service Thermo Fisher Expands Direct-to-Patient Service
    Vetio Animal Health Vetio Animal Health
    HPAPI Technology Trends HPAPI Technology Trends
    Be The Match BioTherapies, Cryoport Enter Agreement Be The Match BioTherapies, Cryoport Enter Agreement
    Finding the Right Partner Finding the Right Partner
    Bioclinica Introduces Expanded ‘SMART’ Technology Suite Bioclinica Introduces Expanded ‘SMART’ Technology Suite
    Catalent, Aucta Pharma Ink Commercial Mfg. Pact Catalent, Aucta Pharma Ink Commercial Mfg. Pact
    Tjoapack, Veratrak Partner for Blockchain Tjoapack, Veratrak Partner for Blockchain
    TraceLink Expands Supply Chain Solutions Portfolio TraceLink Expands Supply Chain Solutions Portfolio
    ACG, Verinetics Partner for Track & Trace ACG, Verinetics Partner for Track & Trace
    Almac Clinical Technologies Launches Podcast Almac Clinical Technologies Launches Podcast
    TrakCel, Mustang Ink Supply Chain Deal TrakCel, Mustang Ink Supply Chain Deal
    Keeping a product’s supply chain on track Keeping a product’s supply chain on track
    The Chain of Compliance The Chain of Compliance

    Related Features

    • Clinical Trials | Information Technology | R&D
      Decentralized Trials Fuel AI Revolution in Clinical Research

      Decentralized Trials Fuel AI Revolution in Clinical Research

      The life sciences industry is giving clinical a full makeover, dramatically improving how new therapeutics are developed.
      Nick Moss, Vice President of Analytics and Machine Learning, Medable 11.17.20

    • Clinical Trials | Information Technology
      The Role of Electronic Monitoring in Maintaining Medication Adherence

      The Role of Electronic Monitoring in Maintaining Medication Adherence

      Digital solutions offer hope to get patients to take their medications properly.
      Bernard Vrijens, Scientific Lead, AARDEX Group 10.14.20

    • Information Technology
      You Need Solutions, Digitization is the Answer

      You Need Solutions, Digitization is the Answer

      Cloud technology helps today’s contract manufacturers be agile, transparent and efficient.
      Brian Curran, Senior Vice President of Strategic Growth, MasterControl 10.14.20


    • Information Technology
      Five Ways to Enhance Clinical Operational Efficiencies Utilizing AI

      Five Ways to Enhance Clinical Operational Efficiencies Utilizing AI

      The proven promise and huge potential of using AI and ML to accelerate drug discovery.
      Lucas Glass, Gary Shorter, and Rajneesh Patil, IQVIA 11.20.19

    • Information Technology
      A Brave New World of Data Integrity

      A Brave New World of Data Integrity

      How modern CMOs are keeping up with stringent regulatory guidelines by embracing advanced laboratory information systems.
      Bob Voelkner, VP Sales and Marketing, LabVantage 06.13.19

    • Clinical Trials | Information Technology
      The New Horizon: Metaprise Analytics in Life Sciences

      The New Horizon: Metaprise Analytics in Life Sciences

      Going beyond enterprise analytics to metaprise analytics—patient-centric systems that create a data driven trial team.
      Michelle Longmire, MD, CEO and Founder, Medable 05.07.19


    • Information Technology
      The Manufacturing Revolution In Medicine

      The Manufacturing Revolution In Medicine

      Real-time data insights help both pharma companies and contract manufacturers meet regulatory requirements while ensuring high production standards.
      Petter Moree, OSIsoft, LLC 05.07.19

    • Information Technology
      Industry 4.0 in the Pharma Industry

      Industry 4.0 in the Pharma Industry

      Digitization is not a single-handed project.
      Dr. Christian Hanisch, Project Manager Industry 4.0 Pharma, Bosch Packaging Technology 03.06.19

    • Information Technology
      Digitization: Pharma 4.0

      Digitization: Pharma 4.0

      A look at how technology is impacting the pharma industry
      Fatih Kaya and Gerald Buerkle, Vetter Pharma 01.25.19


    • Information Technology
      FDA & Data Integrity

      FDA & Data Integrity

      FDA Publishes Final Guidance on Data Integrity
      Robert Marohn, Director of Quality Business Systems, Kite Pharmaceutical 01.25.19

    • Information Technology | Serialization | Supply Chain
      Serialization Compliance

      Serialization Compliance

      Automated data controls during packaging help improve compliance.
      Miguel Pitarch, Executive Director, Global Serialization, Bristol-Myers Squibb & the Bristol-Myers Squibb Serialization Team 11.13.18

    • Drug Development | Information Technology | R&D
      CRO Industry Update: Big Data Drives Drug Development Efforts

      CRO Industry Update: Big Data Drives Drug Development Efforts

      With growth in virtual trials and RWE, the clinical development landscape may never look the same
      Kristin Brooks, Managing Editor 05.11.18


    • Information Technology | Serialization
      Stripping Serialization Back to Data Integrity

      Stripping Serialization Back to Data Integrity

      Why companies can’t afford to make compromises on quality
      Rachna Mohanka, Sr. Director, Global Solution Consulting, TraceLink 05.08.18

    • Information Technology | Regulatory Affairs
      Data Integrity: A Practical  and Risk-Based Approach

      Data Integrity: A Practical and Risk-Based Approach

      Ways an organization can form a culture and cost-effective means to meet the various challenges in sustaining data integrity.
      Robert Marohn, ClinLogic, LLC 09.06.17

    • Drug Delivery | Fill/Finish | Information Technology | Lyophilization | Serialization | Supply Chain | Vials
      Packaging Equipment Close-Up

      Packaging Equipment Close-Up

      To meet the wide-ranging needs of the marketplace, suppliers and contract packagers are looking to deliver flexible solutions.
      Kristin Brooks, Contract Pharma 03.09.16

    Trending
    • The Future Of Clinical Trials Series: Part I
    • Thermo Fisher Buys Novasep's Viral Vector Manufacturing Biz
    • Lonza To Exit Pharma Softgels And Liquid-Filled Hard Capsules
    • Nexelis Acquires GSK Vax Lab In Marburg
    • CDMO Northway Biotech Expands In U.S.
    Breaking News
    • WDSrx Expands Warehouse Network
    • Piramal Inks Clinical Supply Deal with Theratechnologies
    • Recipharm Signs Manufacturing Deal with Enzymatica
    • CDMO Northway Biotech Expands in U.S.
    • Global Biosciences Co. Selects ValGenesis VLMS
    View Breaking News >
    CURRENT ISSUE

    November/December 2020

    • Modeling Process Safety Workflows in Pharmaceutical Manufacturing Scale-Up
    • Ensuring Quality During the Transfer and Scale Up of Rx Drugs
    • Inspecting the Unexpected
    • Cold Chain Trends
    • Catering for the Complex
    • Biopharma Contract Manufacturing: Robust Growth Ahead
    • DCAT President Talks COVID-19, Drug Manufacturing and Innovation
    • The Single-Use Mixing Landscape: Evaluating Your Options
    • Self-Medication: Flexibility for Patients and Drug Manufacturers
    • Decentralized Trials Fuel AI Revolution in Clinical Research
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    NIH Study Compares Low-Fat, Plant-based to Low-Carb, Animal-Based Diet
    Gadot Positions Mineral Line for Vegan Market
    Nutritfy India to Launch Global Broadcast Channel Covering Nutrition
    Coatings World

    Latest Breaking News From Coatings World

    IGL Coatings Launches Graphene Reinforced Dual System Ceramic Coating
    Miller Paint Declares Simple Serenity its 2021 Color of the Year
    TAUBMANS Paint by PPG Releases ‘Chromatic Joy’ Palettes
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    TPI Partners with Zeiss
    PPE Moves into New Manufacturing Facility
    Neurent Medical Closes $25 Million Series B Financing
    Contract Pharma

    Latest Breaking News From Contract Pharma

    WDSrx Expands Warehouse Network
    Piramal Inks Clinical Supply Deal with Theratechnologies
    Recipharm Signs Manufacturing Deal with Enzymatica
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Lageen Tubes Launches Mono-Material PE Tube Solutions
    Jason Jones Loses Battle with Covid-19
    Weleda Celebrates 100 Years By 'Opening' Its Gardens
    Happi

    Latest Breaking News From Happi

    NY's 1,4-Dioxane Law May Impact Concentrated Cleaners
    Sabinsa's Top Scientist Addresses US FDA
    Ipsy Adds New Personal Care Brand
    Ink World

    Latest Breaking News From Ink World

    Morancé Soudure France Adds Comexi F2 MC 10-color Flexo Press
    THIMM Group Installs 1st Koenig & Bauer CorruFLEX
    Cowan Graphics Adds Fujifilm Inca OnsetX3 HS
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Lemu Group engineers mask-making machine
    Niagara Label upgrades with Nilpeter flexo press
    Soma partners with Moore & Moore in US
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Lemu Group Engineers Mask-Making Machine
    Armbrust American Adds Meltblown Manufacturing
    P&G Reports 8% Sales Increase
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    Siemens Healthineers’ DR Systems Cleared by FDA
    Former Medtronic Exec Appointed Zimmer Biomet's Chief Transformation Officer
    SeaSpine Launches Regatta Lateral Plates
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    UDC Subsidiary Adesis' Website Wins 2020 MarCom Platinum Award
    Roadsimple Modernizes Warehouse Ops with Zebra Technologies
    Graphene Flagship Launches Redesigned Website

    Copyright © 2021 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login